Innovative Drug Research and Development in Russia

CJSC R-Pharm is a Russian high-tech pharmaceutical enterprise founded in 2001 in Moscow.

Key areas of R-Pharm’s competence include: manufacturing of finished drugs and APIs, R&D of innovative pharmaceutical products and technologies, market access, sales and marketing of pharmaceuticals, training and education for industry and health care specialists.

The company has the ready production site in Novosibirsk (Novosibkhimfarm plant), GMP certified packing plant in Kostroma (CJSC Ortat), pharmaceutical plant in Yaroslavl.

Baker Botts is an international law firm with 725 lawyers and a network of 13 offices. We are recognized as a leading firm in the energy, technology and life sciences sectors.

The firm has earned the privilege of working on some of the most fascinating and complex legal matters. Throughout our 170-year history, we have provided effective legal solutions for our clients while demonstrating an unrelenting commitment to excellence.

www.bakerbotts.com

Goltsblat BLP,

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry. The company focuses on single-use technologies and value-added services.

Pepeliaev Group is the leading Russian law firm. With more than 160 attorneys based in Moscow and St. Petersburg, Pepeliaev renders legal services in Russia, the CIS, and abroad. Key services include tax advice and tax litigation; corporate; commercial/M&A; antimonopoly regulation; land, real estate and construction; dispute resolution and mediation; intellectual property and trade marks; employment and migration law; banking; customs and foreign trade regulation; administrative and criminal defense for businesses; telecommunications services; pharmaceuticals and healthcare; environmental protection, etc. The firm has more than 800 clients in different industries, most of which are multinational corporations implementing long-term investment projects in Russia.

Xcellerex is commercializing turnkey biomanufacturing solutions that transform the speed and economics of producing therapeutic proteins, including biosimilars and vaccines. Xcellerex’s FlexFactory® is a complete modular and portable production train based on Single‐use technologies, advanced process automation, and compact clean room architecture. FlexFactory allows deployment of GMP manufacturing capacity more rapidly and at greatly reduced costs compared with traditional facilities. Through its BridgeSourcing™ services, Xcellerex manufactures a partner’s biomolecules while the partner prepares for commissioning of its own new FlexFactory. When the partner’s facility is ready, Xcellerex deploys its TransPlant™ process to install, validate and train partner personnel in their own FlexFactory. This parallel‐path model both accelerates time to clinical and commercial manufacturing and allows partners to manage the development and market risks associated with adding manufacturing capacity. Xcellerex also leverages its proprietary single use technologies through the sale of XDR bioreactors, XDM Quad Mixers, and related single‐use assemblies

http://www.xcellerex.com/

Biotek Corporation

The company was founded in 2007. The team of Biotek Corporation is constituted of  experienced managers, scientists, physicians, nutritionists and pharmaceutists. Mission of the company is R&D of know-hows for pharmaceutical and nutritional market operators.

Basic principles of Biotek corportaion:
-    R&D of substances produced by fine organic synthesis,
-    drug design from the research of the desired action to the organic synthesis of the substance,
-    development of a project till the operational level enabling to transfer it to specialized pharmaceutical companies,
-    scrupulous care for patent protection.

The enterprise is located in EKOTEK PLUS Industry & Technology Park, close to the pharmaceutical cluster of St.Petersburg.

Contact information:
Biotek Ltd.
EKOTEK PLUS Industry & Technology Park,
3 Volkhonskoye Shosse,
St.Petersburg, Russia 198323
Tel.: (812) 7024010, fax: (812) 7024014,
e-mail: info@bioteck.ru

As the industry’s #1 choice for VMware storage and data management, EMC leads the way to accelerate the journey to your cloud. The first step to build a private cloud – which delivers the same efficiency and agility  as public clouds, yet you retain the same trust, control, reliability and security you have today. 
Operating your cloud then frees-up operating funds to invest in value-add projects, making big data projects possible. And businesses that successfully harness big data and analytics to improve their strategy  will distance themselves from competitors. 

With $17B in annual revenue and approximately 50,000 employees around the world, EMC is a global leader in enabling businesses and service providers to transform their operations and deliver IT as a service. Fundamental to this transformation is cloud computing.  Through innovative products and services, EMC accelerates the journey to cloud computing, helping IT departments to store, manage, protect and analyze their most valuable asset – information – in a more agile, trusted and cost-efficient way.

www.russia.EMC.com.

Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 152,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve their potential.

Ernst & Young expands its services and resources in accordance with clients’ needs throughout the CIS. 4,000 professionals work at 18 offices in Moscow, St. Petersburg, Novosibirsk, Ekaterinburg, Kazan, Krasnodar, Togliatti, Yuzhno-Sakhalinsk, Almaty, Astana, Atyrau, Baku, Kyiv, Donetsk, Tashkent, Tbilisi, Yerevan, and Minsk.

For more information about our organization, please visit www.ey.com

Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.

State Corporation “Bank for Development and Foreign Economic Affairs (Vnesheconombank)” is one of the key instruments of the state investment strategy.
Vnesheconombank seeks to enhance competitiveness of the Russian economy, its diversification and encourage investment activities.
The Bank’s special status, activity goals, functions and powers are explicitly formulated in Federal Law “On Bank for Development”. 

«Pharmaceutical reporter» possesses the comprehensive experience in cooperation with wide  layers of society in pharmaceutical and medical community–  15 years on the market
«Pharmaceutical reporter»  - is an unique edition in pharmaceutical press, which has  the certified circulation of 16200 exemplars.

It is a pharmaceutical edition issued every week with regional representatives in 68 towns of Central, North-West and Volga regions, Siberia, Urals, Far East, Northern Caucasian of the Russian Federation
edition@pharmvestnik.ru
www.pharmvestnik.ru

“Remedium” Group of Companies renders the whole range of services for specialists in the field of medicine and pharmaceutics. For years the principle directions of activity of “Remedium” Group of Companies are publication of particularized periodicals, assignment of electronic databases, arrangement and implementation of measures, rent-a-rep service, organization of advertisement and PR support.

Bakuninskaya st. 71, bld. 10, 105082, Moscow, Russia
t: (495) 780-34-25; f: (495) 780-34-26;
e-mail: remedium@remedium.ru
www.remedium.ru, www.rosapteki.ru

www.pharma.net.ua is the First independent pharmaceutical business-portal.

It’s target audience is management and leading experts on pharmaceutical market.
Our main tasks are:
1. To accumulate information about services and products, proposed and provided for pharmaceutical market.
2. To create a unified Internet-platform for regular professional communication between pharmaceuticals and people involved both in Ukraine and abroad.
The portal main sections are:
- news
- interviews video
- articles and publications
- events (including special event schedule for target audience)

RIA Novosti is a leading Russian news media organization, with a history spanning 70 years. Today the group incorporates the eponymous multimedia international news agency, a Russian Legal Information Agency (RAPSI), a business news agency (PRIME), a sports news agency (R-Sport), a rating agency, a publishing house (Moskovskiye Novosti, or Moscow News) and a wide network of media centers in Russia and abroad, as well as over 40 websites in 14 languages, with an overall audience of over 17 million unique visitors per month.

4 Zubovsky Boulevard, Moscow 119021, Russia

Phone: +7 (495) 645-6405

Fax: +7 (495) 637-2746

E-mail: sales@rian.ru, http://ria.ru/

Журнал «Фармацевтическая отрасль»

Ведущее украинское издание о и для фармацевтической промышленности. В нем представлена аналитическая информация об открытиях и разработках, оборудовании, технологиях, новых препаратах, бизнес-решениях для предприятий фармацевтической промышленности, дистрибьюторских и аптечных сетей. Мы также печатаем информацию о законодательных актах в области фармацевтики, новости отрасли, интервью, обзоры рынков, исторические данные, практические кейсы, и многое другое.

Website: www.promoboz.com

The media project GMP News is designed as a news digest - an overview of recent news and events in the field of pharmaceutical development and incorporating GMP standards in Russia, Ukraine, Kazakhstan and other countries. The main sources of information are mass media, press centers of various pharmaceutical companies, fairs, conferences…

SCRIPIntelligence is the leading source of pharmaceutical and biotech news, analysis and data, providing expert knowledge on global pharma issues from M&A deals and business to R&D, drug delivery and clinical trials. SCRIP analyses significant facts, trends and predictions to save you time and give you invaluable insight.

Practical Pharmacist is a popular science magazine for the professionals of pharmaceutical industry of Ukraine. It is published monthly since 2003. The magazine features regular sections on the latest achievements of domestic and foreign pharma, medical and pharmacological news,  treatment of internal diseases, practical recommendations to pharmacists. Front-desk pharmacists, managers, producers and distributors are the readers of the magazine.
practik@pharmapractik.kiev.ua
Tel. +38 044 498 06 72**
Fax: +38 044 498 06 74*

"Фармацевтическая промышленность" - информационно-аналитический журнал, выпускаемый АРФП. Издание отражает взгляды лидирующих фармацевтических производственных компаний, выражает определенную и ясную точку зрения на события и проблемы. Периодичность - один раз в два месяца. Заявленный тираж - 5000 экземпляров

TT-TOTAL is an online, in-depth multiple source intelligence and information platform in both English and Russian, covering 30 countries from Central Europe to Central Asia, and 44 sectors from aerospace and defence to metals and mining. With detailed coverage of news on over 700 companies and nearly 400 business and political figures in the region, TT-TOTAL offers unrivalled speed and flexibility to its subscribers. The service is provided by Templeton Thorp, the definitive independent market specialist for all forms of intelligence, business and political information, and due diligence in the former Soviet Union and Central, Southern and Eastern Europe.

Website: www.tt-total.com

THE KAZAKHSTAN PHARMACEUTICAL HERALD
Orbita 1, b. 2,
Almaty, 050043, Kazakhstan
tel./fax +7 (727) 255-00-09
e-mail vestnik@pharmnews.kz
web    www.pharmnews.kz

Informational and analytical newspaper for the drug market participants.
“The Kazakhstan Pharmaceutical Herald” is issued since November 1995 twice a month and distributed to all regions of Kazakhstan.
"KPH" is a source of reliable information on the pharmaceutical market of Kazakhstan:
The problems of production, wholesale and retail business.
The analytical reviews: import, export, production, retail and hospital sales of medicines.
The new laws and normative legal statements. Registration of medicines and medical items.
PR-articles, advertisements.
The web-site of "KPH" is one of the best pharmaceutical web-resources of the CIS. Here is placed the information on registered medicines, medical items and equipment, legislative basis of the industry, wholesale prices on medicines.

Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. 

Pharm-Med.ru - a professional network, an informational and forum platform and also the tool for job search and professionals for pharma and healthcare sectors.
One of most important projects of Pharm-Med.ru is Pharm-Start Project. The aim of Pharm-Start is to connect graduates of pharmaceutical High Schools, pharmaceutical faculties and potential employers.

EUROMONITOR INTERNATIONAL

Euromonitor International is the world's leading provider of strategic market research on industries, countries and consumers.  With its head office in London, offices in Chicago, Singapore, Shanghai, Dubai, Cape Town, Santjago and Vilnius, Euromonitor International has more than 35 years experience of producing market reports, which are published in a variety of formats, from our award-winning online databases, bespoke tailor–made  research projects to market reports and statistical reference books.
We cover 205 countries across the globe with extended country, consumer and industry analysis for 80 national markets. With over 700 analysts and consultants worldwide, Euromonitor International has an unrivalled research network specialising in global consumer markets and service industries. The Company's in-house Consulting division also undertakes customised research projects on all sectors, including industrial, business to business and high-tech industries.

The Pink Sheet - Since 1939, this “Bible” of the prescription pharmaceutical industry has provided expert, in-depth analysis of regulatory, legislative, legal and business developments shaping the industry.
For a free trial of "The Pink Sheet" http://pages.elsevierbi.net/PinkFT/

PharmAsia News - Delivers daily regulatory and business intelligence from bureaus across Asia and other emerging markets, plus exclusive interviews, guest columns and editor’s picks from the local press.
For a free trial to PharmAsia News, email j.berlin@elsevier.com

The Journal "Cellular Transplantation and Tissue Engineering" is unique scientific informational and analytical resource for specialists who work on technology applying, research and manufacturing management of cell, gene and post genome technologies. This edition is for science researchers, for a wide audience interesting of innovation medical technologies. In 2006 the journal was accepted and recommended by the superior certification commission of the Education Department of the Russian Federation Government for publications for submitting scientific studies.
Beginning with the Millennium there was an unprecedented increase of interest in cellular technologies. And not least this is due to the potential of these technologies in clinical treatment. At the same time there is a big gap in fundamental knowledge in that active area of science. We state our goal to fill the void with high quality original scientific material.

www.pharmaphorum.com is the dynamic online information and discussion portal for the pharmaceutical industry. Featuring news, articles, events / company listings and online discussion pay us a visit today to stay informed on the latest trends in the world of pharma and hear of special offers. More features coming soon!

LLC “Publishing Holding “Media Medica”, which in 2009 celebrated its  ten year anniversary, is one of the leading  medical publishing houses in Russia.
Publishing Holding releases 26 magazines for the postgraduate education for  the doctors in different fields, as well as professional  books, abstracts, methodoligal instructions and monographs.
Publishing Holding cooperates with more than 1000 of the most recognized scientists in the country.  Media Medica communicates with all the largest local and international pharmaceutical companies, represented on the Russian market.
All the medical magazines are distributed all over Russia free of charge.
The Data base contains more than 196 000 individuals adresses of doctors.  Media Medica is able to deliver  very accurate direct mail in cardiology, pulmonology, gastroenterology, oncology, gynecology, pediactrics, dermatology, etc.
Web site – www.consilium-medicum.com has over 3000 unique users every day.

«NewScientist RU» - a science publication; a Russian version of the popular British weekly publication. Magazine «New Scientist RU» - a diary of Science and Technology, a literary reflection of what is happening in a rapidly changing high-tech world. The mission of the magazine is to promote creative development and professional growth in the post-industrial society.

www.newscientist.ru

"Science and Technology of Russia» STRF.ru ​​- an electronic publication that aims to actively promote science and technology sectors in order to enhance national competitiveness. STRF.ru ​​infrastructure project is aimed at creating and maintaining an information stream to potential investors and the public about the status and development of R&D sector in Russia, as well as emerging technologies that are created and implemented as part of federal target programs.

www.strf.ru

International science journal ActaNaturae, dedicated to various aspects of the sciences of living. Editorial policy of publication is aimed at cooperating with leading national scientists and enabling them to publish surveys on topical scientific issues and results of their research. A special place in the journal is dedicated to biotechnology, biopharmindustry and innovative development in these areas.

Journal ActaNaturae focuses on the interdisciplinary nature of research and development that are at the crossroads of various fields of biological disciplines - molecular biology, biochemistry, molecular genetics and biological medicine.

"Biorecode" is a consulting company providing of project due diligence and package as well as investment consulting services in the field of innovative biotechnology. "Biorecode" specializes in development projects for novel drug candidates, innovative medical equipment and other health products, offering their clients relationships and knowledge of the strong international team with extensive experience in biopharmaceutical development and sectoral regulation.

Association of the Russian pharmaceutical manufactures (ARPM) was established in 2002 as a non-commercial partnership bringing together leading Russian pharmaceutical companies.
Currently the ARPM unites about 20 pharmaceutical plants which are situated in all Russian regions: Moscow, St. Petersburg, Nizhniy Novgorod, the Urals, Siberia and the Far East. Their share in the market of domestic medical forms (tablets, suspensions, ampoules, aerosols, mixtures etc.) in Russia makes more than 50 percents. Our enterprises completely meet international pharmaceutical standards (Good Manufacturing Practice) and produce not only generic drugs but also the original branded medicaments.

E-mail:arfp@arfp.ru

Website: http://www.arfp.ru/

The Association of International Pharmaceutical Manufacturers operates in Russia since 1994, represents the interests of more than 50 international pharmaceutical companies. AIPM members account for more than 80% of the world pharmaceutical production and more than 60% of drug import to Russia. The main AIPM principles are adherence to innovation, observance of intellectual property rights, and high ethical standards in promotion of medicine.

Website: www.aipm.org/

Mid-Atlantic - Russia Business Council (MARBC)
Since 1994, the Mid-Atlantic - Russia Business Council (MARBC) has worked to foster business relations between Russia and the Commonwealth of Independent States and the U.S. Mid-Atlantic region; one of its main priorities has been Russian-American cooperation in fields including biotechnology, pharmaceuticals, and advanced materials/nanotechnology. MARBC hosts more than 20 events annually in the United States. Organized by the MARBC, the Biotechnological Russian-American Innovation Technology Week (RANIT-BIO), including Russian participation in BIO, is the most significant annual event devoted to Russian-American biotechnology cooperation. Additionally, MARBC facilitates American participation in several of the most significant biotechnology and life sciences events in Russia. 
Website: http://ma-rbc.org 
E-mail:   info@ma-rbc.org  •  val@ma-rbc.org

Коммуникационная группа «ПРАКТИКА» - эксперт в области разработки и реализации проектов в сфере Government&Public Relations/ Market Access для отечественных и международных фармацевтических компаний на российском рынке здравоохранения. Амбициозная команда, 6 лет эффективной работы, более 100 успешно реализованных проектов, собственный эксклюзивный тренинг «Government relations and market access в сфере здравоохранения» - самые очевидные причины, благодаря которым нас называют профессионалами.
www.praktika.ru

Interfax Information Services Group provides professional information products and communications for decision-making in politics and business. Interfax offers a full range of services to government agencies, public organizations, business and the media. Our products and services are political and economical news, real-time news from Russian regions and the CIS, exchange information, analysis, business references on companies, the SPARK and SCAN databases, ratings and rankings, credit reports, IR services and services in the information disclosure sector, organization of press conferences and e-advertising.

Operating in Russia, China and on other emerging markets of Eurasia, Interfax publishes more than 3,000 news items on its wire every day and offers its clients over 100 different information products. The group has unparalleled experience in collecting, processing, storing and distributing original high-quality information and developing innovative technological solutions to deliver it, as well as a long-standing reputation of an impartial, reliable and independent news source. Partners of Interfax are prominent global business players such as Dun & Bradstreet, Experian, Moody’s and Business Wire.

Interfax has clients among government agencies of leading countries, major Russian and international media outlets, companies, banks, financial market players and investors.    

Russia, 127006, Moscow,
2 Pervaya Tverskaya-Yamskaya st., building 1
Т. +7(499)250-98-40
F. +7(499)250-97-27
Web-site: www.interfax.ru
e-mail: info@interfax.ru

SCAN, Interfax Group product, - a new search database for analysis and media monitoring:
- The broadest range of sources at your disposal: newswires, newspapers, magazines, Internet, TV, radio
- Easy-to-use search tool for monitoring business information
- Automatic news monitoring with e-mail notifications
- Graphic and statistical analysis of content
- Profiles of 60000+ Russian companies, 50000+ biographies
- Integration with SPARK, the largest database of Russian, Ukrainian and Kazakh companies

www.scan-interfax.ru | +7 (495) 787-43-43 | E-mail: sales@interfax.ru

Join ‘Innovative Drug R&D in Russia’ Group on LinkedIn to meet industry experts and for latest industry updates
http://www.adamsmithconferences.com/hr18LNK